CompletedPHASE1, PHASE2NCT00622895

Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fred Hutchinson Cancer Center
Principal Investigator
George Georges, M.D
Fred Hutch/University of Washington Cancer Consortium
Intervention
fludarabine phosphate(drug)
Enrollment
3 enrolled
Eligibility
70 years · All sexes
Timeline
20062017

Study locations (2)

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00622895 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials